Login / Signup

A neutralizing single-domain antibody that targets the trimer interface of the human metapneumovirus fusion protein.

Marlies BallegeerRevina C van ScherpenzeelTeresa DelgadoMaria Iglesias-CaballeroBlanca García BarrenoShubham PandeyScott A RushJoost A KolkmanVicente MasJason S MclellanXavier Saelens
Published in: mBio (2023)
Human metapneumovirus (hMPV) is an important respiratory pathogen for which no licensed antivirals or vaccines exist. Single-domain antibodies represent promising antiviral biologics that can be easily produced and formatted. We describe the isolation and detailed characterization of two hMPV-neutralizing single-domain antibodies that are directed against the fusion protein F. One of these single-domain antibodies broadly neutralizes hMPV A and B strains, can prevent proteolytic maturation of F, and binds to an epitope in the F trimer interface. This suggests that hMPV pre-F undergoes trimer opening or "breathing" on infectious virions, exposing a vulnerable site for neutralizing antibodies. Finally, we show that this single-domain antibody, fused to a human IgG1 Fc, can protect cotton rats against hMPV replication, an important finding for potential future clinical applications.
Keyphrases
  • endothelial cells
  • induced pluripotent stem cells
  • climate change
  • zika virus
  • monoclonal antibody